Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

11 Dec 2015 07:00

RNS Number : 7616I
MJ Gleeson PLC
11 December 2015
 

MJ Gleeson PLC

(GLE.L)

 

AGM Statement

 

At the Annual General Meeting of M J Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, convened for 11:30 am today in London, the Chairman, Dermot Gleeson, will state:

"Gleeson Homes has performed strongly in the five months to November 2015, during which it has completed 314 sales (compared with 259 sales in the equivalent period last year). The Government's Help to Buy scheme remained popular during the period, with 53% of customers taking advantage of it. Our own bespoke purchaser assistance packages also continued to be attractive.

"The division currently has 44 active sites, compared with 39 at this time last year. A significant number of sites are due to open and management expects the number of active sites to be approaching 50 by June 2016.

"Gleeson Homes currently has a land pipeline of 7,717 plots, of which 4,003 are owned and 3,714 are conditionally purchased, along with a further 961 plots actively being considered.

"The outlook for the division continues to be very encouraging, with strong customer demand in all regions, supported by improved mortgage availability. We are encouraged by the Halifax Building Society's announcement that it will increase its maximum financial exposure to housebuilders' individual development sites from 30% to 50% of total value and we welcome the announcement of further measures to encourage house building in the Autumn Statement.

"Against this very positive background, the Board expects Gleeson Homes to record an increase in completions for the year to 30 June 2016 of not less 15% compared with the prior year total of 751 units.

"In the first five months of the current financial year, Gleeson Strategic Land has performed significantly ahead of the corresponding period last year, selling two sites with planning permission for a combined total of 405 residential units and a site with consent for commercial use on 112.7 thousand square metres.

"The division's land pipeline currently consists of 68 sites, totalling 3,905 gross acres, which have the potential to deliver approximately 21,250 units. The portfolio includes eight sites with either planning permission or a resolution to grant planning permission. Six of these, which will deliver 632 units, are being progressed for sale in the current financial year.

"There are also 20 sites where the division is currently awaiting either the determination of a planning application or the outcome of a planning appeal.

"The Board expects the results, for the Group as a whole, for the first six months to December 2015 to show a strong increase on the first half of the prior financial half year. Based on the current level of trading in Gleeson Homes and the potential for further sales by Gleeson Strategic Land in the second half of the financial year, the Board now believes that results for the full year to 30 June 2016 will exceed expectations."

 

11 December 2015

 

Enquiries:

MJ Gleeson plc

 Tel: +44 1142 612 900

Jolyon Harrison

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

 

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFMMMZVMLGKZG
Date   Source Headline
12th Dec 20227:00 amRNSAppointment of Managing Director of Gleeson Land
8th Dec 20221:26 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:46 pmRNSDirector/PDMR Shareholding
18th Nov 20221:05 pmRNSResult of AGM
18th Nov 20227:00 amRNSAGM Trading Update
8th Nov 202212:34 pmRNSDirector/PDMR Shareholding
4th Nov 20221:31 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRe: Financial Calendar
31st Oct 20227:00 amRNSTotal Voting Rights
21st Oct 20224:21 pmRNSPerformance Share Plan award to Directors & PDMRs
20th Oct 20227:00 amRNSNotice of AGM
12th Oct 20227:00 amRNSRe Directorate
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20221:25 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSRe Directorate External Appointments
5th Oct 20224:15 pmRNSExercise of Options & PDMR Dealing
3rd Oct 202211:55 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSFinal Results
7th Sep 20229:50 amRNSDirector/PDMR Shareholding
31st Aug 20227:00 amRNSTotal Voting Rights
9th Aug 20229:41 amRNSDirector/PDMR Shareholding
1st Aug 202211:28 amRNSNotification of Transaction by Directors/PCA
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20222:26 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSTrading Update & Notice of Results
7th Jul 20229:35 amRNSDirector/PDMR Shareholding
1st Jul 20227:05 amRNSMJ Gleeson achieves medium-term strategic target
30th Jun 20227:00 amRNSTotal Voting Rights
8th Jun 20222:53 pmRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSTotal Voting Rights
12th May 20227:00 amRNSNotice of Trading Update & Results
10th May 20229:54 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSAppointment of Group Sustainability Manager
4th May 20221:09 pmRNSDirector/PDMR Shareholding
29th Apr 20223:30 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSRe Directorate Change
12th Apr 20224:51 pmRNSDirector/PDMR Shareholding
6th Apr 20227:00 amRNSRe DLUHC pledge
31st Mar 20227:00 amRNSTotal Voting Rights
25th Mar 20227:00 amRNSDirectorate changes and committee appointments
17th Mar 20227:00 amRNSDirectorate Change
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
10th Mar 20229:54 amRNSDirector/PDMR Shareholding
10th Feb 20227:00 amRNSHalf-year Report
8th Feb 20224:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.